evidoria

← Back to browse

Good practice Imported

MaRS Discovery District

Canada · Toronto · See the Canada profile · See the Toronto profile

Evidence: Descriptive / self-reported Top 29% 76/100 · Ask Evidence Copilot about this practice

MaRS (est. 2000) is Canada's flagship urban innovation hub in Toronto. By 2022, ventures it supported had created 33,000+ jobs, raised $19B in capital and generated $11.5B in cumulative revenue across life sciences, cleantech, AI and fintech.

33,000 jobs
Jobs created by supported ventures (2010-2022)
19 C$ billion
Capital raised by supported ventures (2010-2022)
11.5 C$ billion
Cumulative revenue generated by supported ventures (2010-2022)
269 companies
Portfolio companies (2024)
39 positions
Staff positions cut in 2024 restructuring (2024)
MaRS Discovery District

Details

Maturity
Established
Promoter
MaRS Discovery District
Period
2000–present
Keywords
urban innovation, life sciences, cleantech, AI, fintech, startup ecosystem

Context

MaRS Discovery District was established in 2000 and opened its first building in Toronto in 2005, next to the University of Toronto and Toronto General Hospital, as an anchor institution linking university research, healthcare innovation and the private sector.

Activities

The campus grew to about 1.5 million square feet across two phases, housing resident ventures, corporate innovation labs and government-backed programmes in life sciences, cleantech, AI and fintech, funded through a mix of government grants, commercial real-estate revenue, philanthropy and programme fees.

Results

By 2022, MaRS-supported ventures had cumulatively created over 33,000 jobs, raised C$19 billion in capital and generated C$11.5 billion in revenue since 2010, according to MaRS's own impact reporting. As of late 2024 the portfolio comprised about 269 companies, including two unicorns, 77 exits and 14 public listings.

Conclusions

In mid-2024 MaRS underwent two rounds of restructuring under successive new CEOs, cutting roughly 39 positions as net revenues fell about 15% below pre-pandemic levels, and the organisation is resetting its strategic mandate. These recent difficulties moderate an otherwise exceptional two-decade impact record.

Implementation
Indicative cost
Very high (> €5M) — A roughly 1.5 million sq ft, multi-phase campus with C$19 billion in capital raised by supported ventures since 2010 indicates a very high-cost, large-scale institution.
Time to results
Long (> 3 years) — Built up over more than two decades from a single 2005 building to a multi-phase campus; the 2024 restructuring signals an ongoing multi-year strategic reset.
Staffing & skills
resident venture teams, corporate innovation lab staff, programme staff (reduced by around 39 positions in the 2024 restructuring)

Conditions for success

  • anchor location adjacent to the University of Toronto and Toronto General Hospital
  • diversified funding across government grants, real-estate revenue, philanthropy and programme fees
  • multi-stakeholder governance spanning university, hospital, government and industry

Common failure modes

  • revenue decline (around 15% below pre-pandemic levels) straining the funding model
  • leadership turnover (two CEOs since 2024) during a strategic reset

Where it fits

Governance type
public-private-academic-hospital partnership
Scale
national flagship hub
Income level
high-income

Commonly funded by

National / regional programmes

Indicative funding routes for practices of this type — always check each programme's current calls and eligibility rules.

Do you run this practice? Claim it — verified implementers get a public contact pathway and can propose corrections.

Data sources

Where this practice's information was retrieved from, and when.

Attachments

Similar practices you may find useful